 |
|
| BREAST CANCER, AN ISSUE OF HEMATOLOGY/ONCOLOGY CLINICS, 21-2
| |
| | |
|
|
To order this title, and for more information, click here
By
Andrew Seidman, MD
Included in series
The Clinics: Internal Medicine,
Description
This issue contains a comprehensive review of the most relevant information about targeted therapies, including preclinical studies as
well as clinical trials that are ongoing. Attention is given to the main Tirosine Kinase inhibitors, such as anti-EGFR and multitargeted
therapies. The newly developed therapies against intracellular pathways responsible for the tumor phenotype (mTOR inhibitors, farnesyltransferase
inhibitors, and heat sock protein inhibitors) are also presented. This information is important because these new drugs are being tested
in the clinical setting
| Bibliographic details |
Hardbound, 240 pages, publication date: JUN-2007
ISBN-13: 978-1-4160-4323-2
ISBN-10: 1-4160-4323-3
Imprint: SAUNDERS
|
041/407
Last update: 10 Sep 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company